Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

Ulcerative Colitis Excellence Forum

Ulcerative Colitis
Excellence Forum
Leaders in the field sharing authoritative insights and institutional best practices.

Gil Y. Melmed, MD
Conference Coverage
04/24/2023
Gil Y. Melmed, MD, reviewed key efficacy and safety data for approved and emerging interleukin IL-12/23 and IL-23p19 inhibitors for the management of inflammatory bowel disease.
Gil Y. Melmed, MD, reviewed key efficacy and safety data for approved and emerging interleukin IL-12/23 and IL-23p19 inhibitors for the management of inflammatory bowel disease.
Gil Y. Melmed, MD, reviewed key...
04/24/2023
Advances in Inflammatory Bowel Disease Network
Jessica Allegretti, MD
Conference Coverage
04/21/2023
Dr Jessica Allegretti addresses the holistic approach to care of patients with inflammatory bowel disease to include active monitoring, follow-up, patient education, and tight control.
Dr Jessica Allegretti addresses the holistic approach to care of patients with inflammatory bowel disease to include active monitoring, follow-up, patient education, and tight control.
Dr Jessica Allegretti addresses...
04/21/2023
Advances in Inflammatory Bowel Disease Network
Raymond Cross, MD
Conference Coverage
04/14/2023
S1Ps may work best for patients with moderate to more moderate-severe range of ulcerative colitis in the outpatient setting, particularly those earlier in their treatment journey, Dr Raymond Cross said during his presentation at the AIBD...
S1Ps may work best for patients with moderate to more moderate-severe range of ulcerative colitis in the outpatient setting, particularly those earlier in their treatment journey, Dr Raymond Cross said during his presentation at the AIBD...
S1Ps may work best for patients...
04/14/2023
Advances in Inflammatory Bowel Disease Network
Florian Rieder, MD
Conference Coverage
04/14/2023
Biologics can help in achieving and maintain remission among patients with Crohn disease, but is it true for patients with ulcerative colitis too? Dr Florian Rieder discussed antitumor necrosis factors and anti-integrins in the treatment of...
Biologics can help in achieving and maintain remission among patients with Crohn disease, but is it true for patients with ulcerative colitis too? Dr Florian Rieder discussed antitumor necrosis factors and anti-integrins in the treatment of...
Biologics can help in achieving...
04/14/2023
Advances in Inflammatory Bowel Disease Network
Jessica Allegretti, MD
Conference Coverage
03/31/2023
A good management strategy in IBD care is one that successfully changes the disease course and improves quality of life.
A good management strategy in IBD care is one that successfully changes the disease course and improves quality of life.
A good management strategy in...
03/31/2023
Advances in Inflammatory Bowel Disease Network
Millie Long, MD
Conference Coverage
03/31/2023
Dr Millie Long reviewed the virtual explosion of new therapies for ulcerative colitis, and how to position them, at the Advances in Inflammatory Bowel Diseases regional meeting.
Dr Millie Long reviewed the virtual explosion of new therapies for ulcerative colitis, and how to position them, at the Advances in Inflammatory Bowel Diseases regional meeting.
Dr Millie Long reviewed the...
03/31/2023
Advances in Inflammatory Bowel Disease Network
Jeffrey Berinstein
Video
03/20/2023
Dr Berinstein recaps his 'pitch' for the use of JAK inhibitors with corticosteroids to control acute severe ulcerative colitis, which he made to the "Shark Tank" panel at the Crohn's & Colitis Congress.
Dr Berinstein recaps his 'pitch' for the use of JAK inhibitors with corticosteroids to control acute severe ulcerative colitis, which he made to the "Shark Tank" panel at the Crohn's & Colitis Congress.
Dr Berinstein recaps his 'pitch'...
03/20/2023
Advances in Inflammatory Bowel Disease Network
Sam Eisenstein
Video
03/14/2023
Dr Eisenstein reviews key reasons to involve a colorectal surgeon early in the care of patients with acute severe ulcerative colitis, rather than waiting until surgery has become a necessity.
Dr Eisenstein reviews key reasons to involve a colorectal surgeon early in the care of patients with acute severe ulcerative colitis, rather than waiting until surgery has become a necessity.
Dr Eisenstein reviews key...
03/14/2023
Advances in Inflammatory Bowel Disease Network
David Hudesman
Podcast
03/07/2023
Dr Hudesman reviews the findings of a post hoc analysis he and colleagues conducted to assess associations between C-reactive protein, partial Mayo score, and efficacy outcomes during tofacitinib induction.
Dr Hudesman reviews the findings of a post hoc analysis he and colleagues conducted to assess associations between C-reactive protein, partial Mayo score, and efficacy outcomes during tofacitinib induction.
Dr Hudesman reviews the findings...
03/07/2023
Advances in Inflammatory Bowel Disease Network
Brian Feagan
Video
03/01/2023
Dr Feagan reviews the findings of the VEGA study, which examined the efficacy of combining guselkumab, an interleukin-23 inhibitor, with golimumab, a tumor necrosis factor inhibitor, compared to using just a single agent in treating patients...
Dr Feagan reviews the findings of the VEGA study, which examined the efficacy of combining guselkumab, an interleukin-23 inhibitor, with golimumab, a tumor necrosis factor inhibitor, compared to using just a single agent in treating patients...
Dr Feagan reviews the findings...
03/01/2023
Advances in Inflammatory Bowel Disease Network

Advertisement

Advertisement

Advertisement